证券代码：300856 证券简称：科思股份 公告编号：2023-062 债券代码：123192 债券简称：科思转债 南京科思化学股份有限公司 关于使用闲置募集资金和闲置自有资金 进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 南京科思化学股份有限公司（以下简称"公司"）于 2023 年 4 月 19日分别召开第三届董事会第九次会议和第三届监事会第九次会议， 审议通过了《关于使用闲置募集资金和闲置自有资金进行现金管理的 议案》，同意公司及子公司在确保不影响正常运营和募集资金投资项 目推进的情况下，使用总额度不超过 5,000 万元人民币的闲置募集资 金和不超过 50,000 万元人民币的闲置自有资金进行现金管理，用于 购买安全性高、流动性好、期限不超过 12 个月的理财产品；公司于 2023 年 5 月 18 日召开第三届董事会第十一次会议和第三届监事会第 十一次会议，审议通过了《关于使用闲置募集资金进行现金管理的议 案》，同意公司及子公司在确保不影响正常运营和募集资金投资项目 推进的情况下，使用总额度不超过 40,000 万元人民币的闲 ...

证券代码：300856 证券简称：科思股份 公告编号：2023-061 债券代码：123192 债券简称：科思转债 南京科思化学股份有限公司 关于使用闲置募集资金和闲置自有资金 进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 南京科思化学股份有限公司（以下简称"公司"）于 2023 年 4 月 19 日分别召开第三届董事会第九次会议和第三届监事会第九次会议， 审议通过了《关于使用闲置募集资金和闲置自有资金进行现金管理的 议案》，同意公司及子公司在确保不影响正常运营和募集资金投资项 目推进的情况下，使用总额度不超过 5,000 万元人民币的闲置募集资 金和不超过 50,000 万元人民币的闲置自有资金进行现金管理，用于 购买安全性高、流动性好、期限不超过 12 个月的理财产品；公司于 2023 年 5 月 18 日召开第三届董事会第十一次会议和第三届监事会第 十一次会议，审议通过了《关于使用闲置募集资金进行现金管理的议 案》，同意公司及子公司在确保不影响正常运营和募集资金投资项目 推进的情况下，使用总额度不超过 40,000 万元人民币的 ...

Fundraising and Investment - As of June 30, 2023, the company has unused funds from its initial public offering totaling CNY 46.87 million, with CNY 21.81 million held in a special account for fundraising[1] - The company has a remaining balance of CNY 4.69 million from its initial public offering, which includes CNY 1.68 million in interest income after deducting fees[1] - The company has permanently supplemented CNY 82.08 million of surplus fundraising into working capital for its main business operations[1] - The company has ensured that the use and disclosure of fundraising are timely, truthful, accurate, and complete, with no violations reported[1] - The company has a cash management balance of CNY 24 million from the convertible bonds fundraising[1] - The cumulative amount of raised funds utilized reached ¥93,217.37, with a total raised amount of ¥150,146.33[84] - The company raised a total of RMB 86,240.32 million from the issuance of 28.22 million shares at RMB 30.56 per share, with a net amount of RMB 78,513.11 million after deducting issuance costs[100] - As of June 30, 2023, the cumulative use of raised funds amounted to RMB 67,295.34 million, with a remaining balance of RMB 4,687.23 million[100] - The company issued 7,249,178 convertible bonds at a total amount of RMB 72,491.78 million, with a net amount of RMB 71,633.22 million after costs, and has used RMB 25,922.03 million of these funds by June 30, 2023[100] - The company has committed to investing RMB 72,491.78 million in projects, with adjustments made to the total investment amount[109] Project Completion and Progress - The company has completed several projects, including the "25000t/a High-end Daily Fragrance Raw Materials and Sunscreen Agent Supporting Project (Phase I)" with a total investment of CNY 359.45 million, achieving 76.80% of the investment progress[2] - The "25000t/a High-end Daily Fragrance Raw Materials and Sunscreen Agent Supporting Project (Phase II)" has a total investment of CNY 11.07 million, with 100% of the investment completed[2] - The "14200t/a Sunscreen Series Products Project" has also reached 100% investment completion with a total investment of CNY 15.40 million[2] - The company has achieved a cumulative investment of CNY 27.61 million in the "25000t/a High-end Daily Fragrance Raw Materials and Sunscreen Agent Supporting Project (Phase I)" by the end of the reporting period[2] - The company reported a total investment of 151,004.89 million for various projects, with 93,217.37 million already utilized[118] - The company has achieved a utilization rate of 100% for the high-end personal care products project, with an investment of 52,590.86 million[118] - The company has a project completion status of 100% for certain investments, indicating successful implementation[101] Financial Performance - The company reported a significant increase in revenue for the first half of 2023, achieving a total of 500 million RMB, representing a 20% year-over-year growth[13] - The company's operating revenue for the first half of 2023 reached ¥1,190,285,137.04, representing a 45.09% increase compared to ¥820,384,654.34 in the same period last year[37] - The net profit attributable to shareholders of the listed company was ¥350,532,725.96, up 138.69% from ¥146,856,811.05 in the previous year[37] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥343,968,473.52, reflecting a 145.60% increase from ¥140,052,112.48 in the same period last year[37] - The net cash flow from operating activities was ¥400,603,210.70, a significant increase of 207.16% compared to ¥130,419,674.31 in the previous year[37] - Basic earnings per share rose to ¥2.0702, an increase of 138.69% from ¥0.8673 in the same period last year[37] - Diluted earnings per share were ¥2.0019, up 130.82% from ¥0.8673 in the previous year[37] - The gross profit margin improved to 35%, up from 30% in the same period last year, reflecting better cost management and pricing strategies[13] Market Expansion and Strategy - User data indicates a growing customer base, with an increase of 15% in active users compared to the previous year, reaching 1.2 million users[13] - The company has set a future outlook with a revenue target of 1 billion RMB for the full year 2023, indicating a 25% growth expectation[13] - New product development includes the launch of three innovative sunscreen products, which are expected to contribute an additional 100 million RMB in revenue by the end of the year[13] - The company is expanding its market presence in Southeast Asia, with plans to enter two new countries by Q4 2023, aiming for a 10% market share in those regions[13] - A strategic acquisition of a local competitor is in progress, which is projected to enhance the company's production capacity by 30%[13] - The company is focusing on expanding its market presence and has restarted overseas exhibitions to enhance brand influence[65] - The company aims to expand its market presence in developing countries as the fragrance and flavor industry shifts towards these regions[47] Research and Development - The company has invested 50 million RMB in R&D for new chemical formulations, focusing on sustainability and eco-friendliness[13] - Research and development expenses increased by 73.07% to ¥60,200,382.74, primarily due to higher personnel costs and material consumption related to R&D activities[87] - The company is focusing on R&D and innovation, developing new products and processes aligned with market demands[65] - The company is focused on continuous technological innovation and brand building to enhance its competitive advantage in the market[48] - The company’s operational model emphasizes technological innovation and quality management, supported by a provincial-level enterprise technology center[61] Environmental and Compliance Efforts - The company has established a comprehensive environmental protection system to manage waste and emissions[133] - The company is committed to continuous improvement in environmental protection and sustainable development practices[148] - The company has made substantial investments in environmental protection and waste treatment systems, enhancing its sustainability efforts[86] - The company reported a total of 66.81 tons of COD emissions and 1.91 tons of ammonia nitrogen emissions from wastewater, indicating significant environmental impact[145] - The main pollutants during the reporting period included noise, waste gas, wastewater, and solid pollutants, with waste gas primarily from natural gas combustion and workshop emissions[145] - The company has complied with environmental monitoring requirements and conducted various emergency response drills[176] Corporate Governance and Management - The company has appointed new vice presidents, including Cao Xiaoru and He Chi, to strengthen its management team[157] - The company is implementing a restricted stock incentive plan in 2023 to enhance employee motivation and retention[157] - The company approved the 2023 Restricted Stock Incentive Plan and its implementation assessment management measures during the board meeting on April 19, 2023[158] - The company has not reported any major litigation or arbitration matters during the reporting period[184] - The company has not engaged in any significant related party transactions during the reporting period[186] - The company has not reported any violations regarding external guarantees during the reporting period[167] Challenges and Risks - The company is exposed to risks related to international trade policies, particularly in light of ongoing trade tensions[134] - The company has faced challenges in project implementation due to personnel movement and material procurement issues, impacting the timeline[123]

证券代码：300856 证券简称：科思股份 公告编号：2023-056 债券代码：123192 债券简称：科思转债 （一）审议通过《关于公司<2023 年半年度报告>及其摘要的议 案》 根据 2023 年半年度经营情况，公司按照相关规定编制了《2023 年半年度报告》及《2023 年半年度报告摘要》。 南京科思化学股份有限公司 第三届董事会第十三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 南京科思化学股份有限公司（以下简称"公司"）第三届董事会 第十三次会议于 2023 年 8 月 17 日以现场结合通讯方式召开，会议通 知已于 2023 年 8 月 7 日以通讯方式通知了全体董事。会议应出席董 事 9 名，实际出席董事 9 名（其中 3 名董事以通讯方式出席）。会议 由董事长周旭明先生主持，公司其他高级管理人员列席了本次会议。 本次董事会会议的召集、召开和表决程序符合有关法律、行政法 规、部门规章、规范性文件和《公司章程》的规定。 二、董事会会议审议情况 经与会董事认真审议，形成决议如下： 公司独立董事对本议案发表 ...

证券代码：300856 证券简称：科思股份 公告编号：2023-060 债券代码：123192 债券简称：科思转债 南京科思化学股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、募集资金基本情况 （一）首次公开发行股票募集资金 1、实际募集资金金额及到位情况 根据中国证券监督管理委员会证监许可【2020】803 号《关于核 准南京科思化学股份有限公司首次公开发行股票的批复》文件核准， 南京科思化学股份有限公司（以下简称"公司""本公司"）由主承销 商民生证券股份有限公司（以下简称"民生证券"）向社会公众公开 发行人民币普通股（A 股）2,822 万股，每股面值 1.00 元，发行价为 每股 30.56 元，共募集资金 86,240.32 万元，扣除发行费用 7,727.21 万元后，实际募集资金净额为 78,513.11 万元。上述募集资金到位情 况已经天衡会计师事务所（特殊普通合伙）出具的天衡验字（2020） 00071 号《验资报告》验证。 2、以前年度募集资金使用及结余情况 截至 202 ...

独立董事对第三届董事会第十三次会议 二、关于公司控股股东及其他关联方占用公司资金和公司对外担保情况 经核查，报告期内，公司严格执行相关法律、法规、规范性文件和《公司章 程》的规定，不存在控股股东及其他关联方非经营性占用公司资金的情况和公司 违规对外担保情况，也不存在以前年度发生并延续至报告期的前述情况。 独立董事：宋兵、崔荣军、郭燏 2023 年 8 月 17 日 南京科思化学股份有限公司 相关事项的独立意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）、中国证券监督管 理委员会《上市公司独立董事规则》《南京科思化学股份有限公司章程》（以下简 称"《公司章程》"）等有关法律、行政法规和规范性文件，我们作为南京科思化 学股份有限公司（以下简称"公司"）的独立董事，对提交公司第三届董事会第 十三次会议审议的相关议案以及关于公司控股股东及其他关联方占用公司资金 和公司对外担保情况进行了审阅。经认真审查相关文件，发表独立意见如下： 一、关于公司《2023 年半年度募集资金存放与使用情况的专项报告》的议 案 经认真审议，我们认为公司编制的《2023 年半年度募集资金存放与使用情 况的专项报告》如实反映了公司 ...

证券代码：300856 证券简称：科思股份 公告编号：2023-057 债券代码：123192 债券简称：科思转债 南京科思化学股份有限公司 第三届监事会第十二次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 南京科思化学股份有限公司（以下简称"公司"）第三届监事会 第十二次会议于 2023 年 8 月 17 日以现场结合通讯方式召开，会议通 知已于 2023 年 8 月 7 日以通讯方式通知了全体监事。会议应出席监 事 3 名，实际出席监事 3 名（其中 1 名监事以通讯方式出席）。会议 由监事会主席刘建生先生主持，公司董事会秘书列席了本次会议。 本次监事会会议的召集、召开和表决程序符合有关法律、行政法 规、部门规章、规范性文件和《公司章程》的规定。 二、监事会会议审议情况 经与会监事认真审议，形成决议如下： （一）审议通过《关于公司<2023 年半年度报告>及其摘要的议 案》 根据 2023 年半年度经营情况，公司按照相关规定编制了《2023 年半年度报告》及《2023 年半年度报告摘要》。 本 议 案 具 体 内 容 ...

南京科思化学股份有限公司 单位：人民币万元 非经营性资金占用 资金占用方名 称 占用方与上 市公司的关 联关系 上市公司 核算的会 计科目 2 023 年期 初占用资 金余额 2 023 年上半年占 用累计发生金额 （不含利息） 2023 年上半年 占用资金的利息 （如有） 2023 年上半年 偿还累计发生 金额 2023 年上半年 期末占用资金 余额 占用形成 原因 占用性质 控股股东、实际控制人及其附属企业 不适用 不适用 不适用 不适用 不适用 小计 - - - - - 前控股股东、实际控制人及其附属企业 不适用 不适用 不适用 不适用 不适用 小计 - - - - - 其他关联方及附属企业 不适用 不适用 不适用 不适用 不适用 小计 - - - - - 总计 - - - - - 其它关联资金往来 资金往来方名 称 往来方与上 市公司的关 联关系 上市公司 核算的会 计科目 2023 年期 初往来资 金余额 2023 年上半年往 来累计发生金额 （不含利息） 2023 年上半年 往来资金的利息 （如有） 2023 年上半年 偿还累计发生 金额 2023 年上半年 期末往来资金 余额 往来形成 原因 往 ...

中信证券股份有限公司 关于南京科思化学股份有限公司 2023 年半年度跟踪报告 | 保荐人名称：中信证券股份有限公司 | 被保荐公司简称：科思股份 | | --- | --- | | 保荐代表人姓名：王风雷 | 联系电话：021-20262057 | | 保荐代表人姓名：艾华 | 联系电话：021-20262205 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次 | 0 次 | | 数 | | | 2．督导公司建立健全并有效执行规章制 | | | 度的情况 | | | （1）是否督导公司建立健全规章制度（包 括但不限于防止关联方占用公司资源的 | 是 | | 制度、募集资金管理制度、内控制度、内 | | | 部审计制度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3.募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 共查询 6 次（每月 1 次） | | （2）公司募集资金项目进展是否与信息 | 是 ...

Business Strategy and Future Plans - The company's future strategy focuses on strengthening and expanding its core businesses of synthetic fragrances and cosmetic active ingredients, aiming to enhance its competitive advantages and international brand influence [3] - Sunscreen products will remain the mainstay of the business, with continued expansion in fragrance, personal care, and other functional personal care product ingredients [3] - The company plans to become a comprehensive supplier of daily chemical raw materials, leveraging its efficient R&D and industrialization capabilities [3] - In the short to medium term, the company will not engage in terminal cosmetics business but will continue to focus on personal care product ingredients [3] - The company is optimistic about the domestic market and has established partnerships with leading domestic brands, planning to continue advancing related businesses [4] Product Development and Market Performance - The company's PA product, which started production in the first half of last year, is expected to see a significant increase in sales this year [4] - Titanium dioxide product, which began trial production at the end of last year, is expected to gradually increase in volume in the second half of this year [4] - Amino acid surfactants, PO, and new P-S production lines are under construction, with a focus on market promotion and customer certification this year [4] - The company's sunscreen products have high gross and net profit margins, with significant barriers to entry for potential competitors [2] - The company has a competitive advantage in product structure, innovation, R&D capabilities, production and quality management systems, and global responsiveness [2] Cost and Pricing - The company's main raw materials include bulk and fine chemicals, with prices influenced by upstream crude oil and other bulk commodity price fluctuations [3] - In cases of significant raw material price increases, the company actively negotiates price adjustments with downstream customers, though there may be delays due to pricing cycles and market competition [3] - Raw material costs have slightly decreased compared to the third quarter of last year, but product prices are not fully synchronized with crude oil prices [5] - The company expects overall price trends to remain stable this year, given strong market demand and customer feedback [5] Sales and Distribution - For large and medium-sized terminal customers, the company primarily uses its own sales system for direct sales [5] - For geographically concentrated but smaller customers, the company relies on distributors to improve efficiency and reduce costs [5] - The two sales models complement each other and do not conflict [5] Human Resources and Organizational Development - The company places a high priority on human resources, continuously improving its talent pool and conducting multi-level talent reserves aligned with its business direction and future development strategy [4] - The company has implemented its first post-listing equity incentive plan and plans to conduct equity incentives every 2-3 years to motivate employees and focus on long-term development [4] - The company's core values emphasize innovation and continuous improvement, aiming to integrate macro concepts into daily work details [4] Industry Barriers and Competitive Landscape - The cosmetic active ingredient market is highly concentrated, with a stable supplier system and high standards for supplier certification, making it difficult for new entrants to gain significant customer resources in the short term [2] - The company has established a strong position in the international cosmetics supply chain through technological innovation and stable quality, continuously increasing its market share [3]